Reduced neutralizing antibody response to SARS‐CoV‐2 vaccine booster dose in people living with HIV with severe immunosuppression

The aim of this study was to assess the immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) vaccines among people living with HIV (PLWH) with severe immunosuppression, after a booster dose. The design was a case–control study nested in a prospective cohort of PLWH. All pat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical virology 2023-03, Vol.95 (3), p.e28602-n/a
Hauptverfasser:	Corma‐Gómez, Anaïs, Fernández‐Fuertes, Marta, Viñuela, Laura, Domínguez, Carmen, Santos, Marta, Fuentes‐López, Ana, Rojas, Almudena, Fernández‐Pérez, Nieves, Martín‐Carmona, Jessica, Serrano‐Conde, Esther, Real, Luis M., Mendoza, Joaquín, Macías, Juan, Pineda, Juan A., García, Federico
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies Antibodies, Neutralizing Antibodies, Viral Antibody Formation Antibody response Case-Control Studies CD4 antigen CD4 T‐cell counts Coronaviruses COVID-19 COVID-19 - prevention & control COVID-19 Vaccines HIV HIV Infections Human immunodeficiency virus Humans Immune response Immune system Immunization Immunogenicity Immunosuppression Immunosuppression Therapy mRNA Multivariate analysis Neutralization Neutralizing people living with HIV Prospective Studies RNA, Messenger SARS-CoV-2 Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Sexually transmitted diseases Statistical analysis STD vaccine Vaccines Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The aim of this study was to assess the immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) vaccines among people living with HIV (PLWH) with severe immunosuppression, after a booster dose. The design was a case–control study nested in a prospective cohort of PLWH. All patients with CD4 cell count
ISSN:	0146-6615 1096-9071
DOI:	10.1002/jmv.28602